ACADIA Pharmaceuticals Inc. vs TORM plc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while TORM plc trades at $28.3 (market cap $2.93B). The key difference: ACADIA Pharmaceuticals Inc. is the larger of the two by market cap, and TORM plc pays a 9.77% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | TRMD | |
|---|---|---|
Market Cap | $5.07B | $2.93B |
Sector | Health | Technology |
52-Week High | $29.41 | $34.87 |
52-Week Low | $20.06 | $18.77 |
Enterprise Value | $4.19B | $3.82B |
Dividend Yield | — | 9.77% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →